Related Experiment Video
Updated: Mar 20, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Perinatal reduction of functional serotonin transporters results in developmental delay
Yvet Kroeze1, Bart Dirven2, Stefan Janssen2
1Donders Institute for Brain, Cognition, and Behaviour, Centre for Neuroscience, Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 EZ Nijmegen, The Netherlands; Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behaviour, Centre for Neuroscience, 6525 GA Nijmegen, The Netherlands.
Insights
Early-life reduction in serotonin transporter (5-HTT) function causes developmental delays but most behavioral effects normalize later. Lifelong 5-HTT inactivation impacts adult object recognition and directed behaviors.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Reduced serotonin transporter (5-HTT) function in early life is linked to neuropsychiatric disorders.
- The impact of altered 5-HTT function on behavior across developmental stages remains understudied.
Purpose of the Study:
- To investigate the effects of perinatal and lifelong 5-HTT inactivation on behavior throughout development.
- To compare the behavioral outcomes of pharmacological and genetic 5-HTT inactivation.
Main Methods:
- Rats were exposed perinatally to fluoxetine or vehicle, and genetic 5-HTT knockout (5-HTT-/-) and wild-type (5-HTT+/+) rats were used.
- A comprehensive battery of behavioral tests assessed motor, olfactory, grooming, sensorimotor gating, and object-related behaviors across postnatal weeks, adolescence, and adulthood.
- Developmental milestones including eye opening, reflex development, and body weight were monitored.
Main Results:
- Both perinatal fluoxetine exposure and genetic 5-HTT inactivation led to developmental delays.
- Most early-life behavioral alterations normalized by adulthood, except for hypo-locomotion.
- Adolescent and adult 5-HTT-/- rats exhibited altered object-directed behavior and impaired novel object recognition.
Conclusions:
- Perinatal and lifelong 5-HTT inactivation induce developmental delays, with most effects resolving over time.
- Lifelong 5-HTT inactivation is associated with persistent changes in object recognition and directed behaviors in adulthood.
- These findings enhance understanding of 5-HTT's role in behavioral development and potential long-term consequences of its inactivation.
Abstract:
While there is strong evidence from rodent and human studies that a reduction in serotonin transporter (5-HTT) function in early-life can increase the risk for several neuropsychiatric disorders in adulthood, the effects of reduced 5-HTT function on behavior across developmental stages are underinvestigated. To elucidate how perinatal pharmacological and lifelong genetic inactivation of the 5-HTT affects behavior across development, we conducted a battery of behavioral tests in rats perinatally exposed to fluoxetine or vehicle and in 5-HTT(-/-) versus 5-HTT(+/+) rats. We measured motor-related behavior, olfactory function, grooming behavior, sensorimotor gating, object directed behavior and novel object recognition in the first three postnatal weeks and if possible the tests were repeated in adolescence and adulthood. We also measured developmental milestones such as eye opening, reflex development and body weight. We observed that both pharmacological and genetic inactivation of 5-HTT resulted in a developmental delay. Except for hypo-locomotion, most of the observed early-life effects were normalized later in life. In adolescence and adulthood we observed object directed behavior and decreased novel object recognition in the 5-HTT(-/-) rats, which might be related to the lifelong inactivation of 5-HTT. Together, these data provide an important contribution to the understanding of the effects of perinatal and lifelong 5-HTT inactivation on behavior across developmental stages.
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Teratogenicity
Socioemotional Development during Infancy
Primary Temperament Types
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

